Prospective observational study of the long term hazards of biologic therapy in rheumatoid arthritis.
Phase of Trial: Phase IV
Latest Information Update: 28 Mar 2018
At a glance
- Drugs Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Etanercept (Primary) ; Infliximab (Primary) ; Rituximab (Primary) ; Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms BSRBR-RA
- 28 Mar 2018 Results (n=19282) assessing rate of serious infections published in the Annals of the Rheumatic Diseases
- 17 Jun 2017 Preliminary results (n= 417) presented at the 18th Annual Congress of the European League Against Rheumatism
- 30 Aug 2013 Planned end date changed from 31 Dec 2014 to 30 Sep 2018 as reported by United Kingdom Clinical Research Network record .